查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1319940

外阴痛治疗市场：按类型、适应症、提供者分类 - 全球预测 2023-2030

Vulvodynia Treatment Market by Type, Indication, Providers - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年全球外阴痛治疗市场将大幅成长555.3亿美元，年复合成长率为9.60%，到2030年将达到1056.7亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球外阴痛治疗市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.外阴痛治疗的全球市场规模与预测为何？

2.在预测期内，COVID-19 对全球外阴痛治疗市场的阻碍因素与影响为何？

3.在预测期内，全球外阴痛治疗市场需要投资哪些产品/细分市场/应用/领域？

4.全球外阴痛治疗市场的竞争策略为何？

5. 全球外阴痛治疗市场的技术趋势和法律规范是什么？

6.全球外阴痛治疗市场主要厂商的市占率为何？

7. 哪些型态和策略性措施被认为适合进入全球外阴痛治疗市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 增加临床医生，特别是妇科医师对外阴痛诊断的了解
      • 医疗保健设施和诊断服务的发展
      • 增加研发活动
    • 抑制因素
      • 不明原因和有限的诊断选择
    • 机会
      • 医生提供外阴痛的自我照顾和治疗
      • 仿单标示外药物的长期可用性
    • 任务
      • 医护人员对外阴痛的了解有限
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化
    • 外阴痛流行病学资料和趋势

第6章外阴痛治疗市场：依类型

  • 生物回馈和物理治疗
  • 病灶内注射
  • 口服治疗
  • 手术治疗
  • 局部治疗

第7章外阴痛治疗市场（依适应症）

  • 全身性外阴痛
  • 局限性外阴炎

第8章外阴痛治疗市场（依提供者划分）

  • 医院和护理提供者
  • 製药和生物技术公司
  • 研发中心

第9章美洲外阴痛治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区外阴痛治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东与非洲外阴痛治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-433BAD49EE74

The Global Vulvodynia Treatment Market is forecasted to grow significantly, with a projected USD 55.53 billion in 2023 at a CAGR of 9.60% and expected to reach a staggering USD 105.67 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Vulvodynia Treatment Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Vulvodynia Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Biofeedback & Physical Therapy, Intralesional Injections, Oral Treatment, Surgical Treatment, and Topical Treatments. The Intralesional Injections is projected to witness significant market share during forecast period.

Based on Indication, market is studied across Generalized Vulvodynia and Localized Vulvodynia. The Generalized Vulvodynia is projected to witness significant market share during forecast period.

Based on Providers, market is studied across Hospitals & Care Providers, Pharmaceutical & Biotechnology Companies, and Research & Development Centres. The Research & Development Centres is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Vulvodynia Treatment Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Vulvodynia Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vulvodynia Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vulvodynia Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Vulvodynia Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Vulvodynia Treatment Market?

6. What is the market share of the leading vendors in the Global Vulvodynia Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Vulvodynia Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Vulvodynia Treatment Market, by Type, 2022 vs 2030
  • 4.3. Vulvodynia Treatment Market, by Indication, 2022 vs 2030
  • 4.4. Vulvodynia Treatment Market, by Providers, 2022 vs 2030
  • 4.5. Vulvodynia Treatment Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing knowledge of vulvodynia diagnostics among clinicians, particularly gynecologists
      • 5.1.1.2. Developments in healthcare facilities and diagnostic services
      • 5.1.1.3. Increase in the number of research and development activities
    • 5.1.2. Restraints
      • 5.1.2.1. Unidentified causes and limited diagnosis options
    • 5.1.3. Opportunities
      • 5.1.3.1. Doctors offering self-care and treatments for vulvodynia
      • 5.1.3.2. Prolonged availability of off-label drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Limited familiarity of health care providers with vulvodynia
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization
    • 5.9.1. Vulvodynia Epidemiological Data & Trend

6. Vulvodynia Treatment Market, by Type

  • 6.1. Introduction
  • 6.2. Biofeedback & Physical Therapy
  • 6.3. Intralesional Injections
  • 6.4. Oral Treatment
  • 6.5. Surgical Treatment
  • 6.6. Topical Treatments

7. Vulvodynia Treatment Market, by Indication

  • 7.1. Introduction
  • 7.2. Generalized Vulvodynia
  • 7.3. Localized Vulvodynia

8. Vulvodynia Treatment Market, by Providers

  • 8.1. Introduction
  • 8.2. Hospitals & Care Providers
  • 8.3. Pharmaceutical & Biotechnology Companies
  • 8.4. Research & Development Centres

9. Americas Vulvodynia Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Vulvodynia Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Vulvodynia Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. VULVODYNIA TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. VULVODYNIA TREATMENT MARKET SIZE, 2022 VS 2030
  • FIGURE 3. VULVODYNIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
  • FIGURE 6. VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2022 VS 2030 (%)
  • FIGURE 7. VULVODYNIA TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. VULVODYNIA TREATMENT MARKET DYNAMICS
  • FIGURE 9. VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. VULVODYNIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. VULVODYNIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. VULVODYNIA TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. VULVODYNIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. VULVODYNIA TREATMENT MARKET SIZE, BY BIOFEEDBACK & PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. VULVODYNIA TREATMENT MARKET SIZE, BY INTRALESIONAL INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. VULVODYNIA TREATMENT MARKET SIZE, BY ORAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. VULVODYNIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. VULVODYNIA TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 11. VULVODYNIA TREATMENT MARKET SIZE, BY GENERALIZED VULVODYNIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. VULVODYNIA TREATMENT MARKET SIZE, BY LOCALIZED VULVODYNIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 14. VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. VULVODYNIA TREATMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. VULVODYNIA TREATMENT MARKET SIZE, BY RESEARCH & DEVELOPMENT CENTRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 144. VULVODYNIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 145. VULVODYNIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 146. VULVODYNIA TREATMENT MARKET LICENSE & PRICING